J&J Closes Australian Research Facility As Part Of Global R&D Restructuring Plan
This article was originally published in PharmAsia News
PERTH, Australia - Johnson & Johnson will close its Australian research facility based in the Australian Technology Park in Redfern as part of a global consolidation and restructuring of its pharma R&D operations, the company announced Aug. 28
You may also be interested in...
BEIJING - Johnson & Johnson's medical device manufacturing base started operation in China's southern city of Suzhou, the company announced April 22
Big Pharma Stretches To Reshape Itself To Enter Asia With Flexible, Multiple-Partner Networks – Singapore Conference
SINGAPORE - As big pharma looks across Asia for new ways of doing business, execs from the top pharma companies agreed that having people on the ground in Asia is critical and that companies are moving away from being fully integrated pharma companies to becoming fully integrated pharma networks
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).